Drugs / Seasonal influenza (flu) vaccine
Seasonal influenza (flu) vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02554188 Background | May 2019 | immunodeficiency disease | University of Southern California | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seasonal influenza (flu) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02554188 ↗ |
| Known as | Fluzone High-Dose | “Fluzone High-Dose (Sanofi Pasteur)” NCT02554188 ↗ |
| Known as | Fluzone Quadrivalent Vaccine | “Fluzone Quadrivalent Vaccine (Sanofi Pasteur), for participants ages 50 - 64 years old” NCT02554188 ↗ |
| Modality | Vaccine | “annual influenza vaccination” NCT02554188 ↗ |